[Diagnostic and therapeutic recommendations for sexually transmitted diseases: Genital herpes].
暂无分享,去创建一个
M. Senat | E. Caumes | B. Milpied | L. Sentilhes | O. Chosidow | É. Caumes | M. Senat | B. Milpied | M. Janier | N. Spenatto | J. Timsit | Michel Janier | Groupe infectiologie dermatologique et infections sexuell transmissibles
[1] V. Jordan,et al. Interventions for men and women with their first episode of genital herpes. , 2016, The Cochrane database of systematic reviews.
[2] N. Lelong,et al. Trends in perinatal health in France from 1995 to 2010. Results from the French National Perinatal Surveys. , 2012, Journal de gynecologie, obstetrique et biologie de la reproduction.
[3] D. Money,et al. Guidelines for the management of herpes simplex virus in pregnancy , 2008, Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC.
[4] L. Hollier,et al. Third trimester antiviral prophylaxis for preventing maternal genital herpes simplex virus (HSV) recurrences and neonatal infection. , 2008, The Cochrane database of systematic reviews.
[5] ACOG Practice Bulletin. Clinical management guidelines for obstetrician-gynecologists. No. 82 June 2007. Management of herpes in pregnancy. , 2007, Obstetrics and gynecology.
[6] S. Tyring,et al. Single-day therapy: an expert opinion on a recent development for the episodic treatment of recurrent genital herpes , 2006, Archives of Gynecology and Obstetrics.
[7] James B. Hill,et al. Valacyclovir Prophylaxis to Prevent Recurrent Herpes at Delivery: A Randomized Clinical Trial , 2006, Obstetrics and gynecology.
[8] W. Andrews,et al. Valacyclovir therapy to reduce recurrent genital herpes in pregnant women. , 2006, American journal of obstetrics and gynecology.
[9] L. Corey,et al. A double-blind, randomized, placebo-controlled trial of acyclovir in late pregnancy for the reduction of herpes simplex virus shedding and cesarean delivery. , 2003, American journal of obstetrics and gynecology.
[10] Lawrence Corey,et al. Two-day regimen of acyclovir for treatment of recurrent genital herpes simplex virus type 2 infection. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[11] P. Sánchez,et al. Acyclovir suppression to prevent recurrent genital herpes at delivery. , 2002, Infectious diseases in obstetrics and gynecology.
[12] D. Luton,et al. Acyclovir prophylaxis in late pregnancy prevents recurrent genital herpes and viral shedding. , 2001, European journal of obstetrics, gynecology, and reproductive biology.
[13] P. Brocklehurst,et al. A randomised placebo controlled trial of suppressive acyclovir in late pregnancy in women with recurrent genital herpes infection , 1998, British journal of obstetrics and gynaecology.
[14] L. Corey,et al. A Randomized, Placebo-Controlled Comparison of Oral Valacyclovir and Acyclovir in Immunocompetent Patients With Recurrent Genital Herpes Infections , 1998 .
[15] K. Fife,et al. Valaciclovir Versus Acyclovir in the Treatment of First‐Episode Genital Herpes Infection: Results of an International, Multicenter, Double‐Blind, Randomized Clinical Trial , 1997, Sexually transmitted diseases.
[16] J. Paavonen,et al. Valaciclovir versus aciclovir in patient initiated treatment of recurrent genital herpes: a randomised, double blind clinical trial. International Valaciclovir HSV Study Group. , 1997, Genitourinary medicine.
[17] S. Tyring,et al. A large-scale, placebo-controlled, dose-ranging trial of peroral valaciclovir for episodic treatment of recurrent herpes genitalis. Valaciclovir HSV Study Group. , 1996, Archives of internal medicine.
[18] P. Sánchez,et al. Acyclovir Suppression to Prevent Cesarean Delivery After First‐Episode Genital Herpes , 1996, Obstetrics and gynecology.
[19] P. Rolan,et al. Absolute bioavailability and metabolic disposition of valaciclovir, the L-valyl ester of acyclovir, following oral administration to humans , 1995, Antimicrobial agents and chemotherapy.
[20] G. Kinghorn,et al. Efficacy of oral treatment with acyclovir and co-trimoxazole in first episode genital herpes. , 1986, Genitourinary medicine.
[21] D. Richman,et al. DOUBLE BLIND PLACEBO-CONTROLLED TRIAL OF ORAL ACYCLOVIR IN FIRST EPISODE GENITAL HERPES SIMPLEX VIRUS INFECTION , 1985 .
[22] Richard J. T. Klein,et al. A collaborative study of patient-initiated treatment of recurrent genital herpes with topical acyclovir or placebo. , 1984, The Journal of infectious diseases.
[23] J. Cherry,et al. Treatment of first episodes of genital herpes simplex virus infection with oral acyclovir. A randomized double-blind controlled trial in normal subjects. , 1983, The New England journal of medicine.
[24] P. de Miranda,et al. Pharmacokinetics of acyclovir after intravenous and oral administration. , 1983, The Journal of antimicrobial chemotherapy.
[25] A. Nilsen,et al. EFFICACY OF ORAL ACYCLOVIR IN THE TREATMENT OF INITIAL AND RECURRENT GENITAL HERPES , 1982, The Lancet.
[26] K. Holmes,et al. Double-blind controlled trial of topical acyclovir in genital herpes simplex virus infections. , 1982, The American journal of medicine.
[27] K. Holmes,et al. A trial of topical acyclovir in genital herpes simplex virus infections. , 1982, The New England journal of medicine.